You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in the United Arab Emirates

Nov 2011

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in United Arab Emirates with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in United Arab Emirates, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in United Arab Emirates for free:

The Consumer Health in United Arab Emirates market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in United Arab Emirates?
  • What are the major brands in United Arab Emirates?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health continues to grow despite recessionary pressures

Consumer health in the United Arab Emirates continued to grow in 2010; however, the economic downturn led to lower current value growth compared with the review period CAGR. The fallout from the economic downturn impacted both volume and value growth; volume growth in terms of lower population growth and a wave of expatriates moving back to their home countries, and value growth in terms of cutting down on products which are considered less necessary, such as vitamins and dietary supplements.

Self-medication rises to the mainstream

Consumer health was supported by the rising trend of self-medication in the United Arab Emirates, as consumers gained confidence in some products, and increasingly relied on these brands for various ailments. Although consumers were historically cautious about self-medication due to their lack of awareness, the government has been actively promoting self-medication in an effort to reduce its spending on healthcare. Penetration of over-the-counter (OTC) products increased alongside this rising demand, which led to further interest, particularly as consumers became more knowledgeable and confident when selecting products.

Julphar remains second despite the strength of international manufacturers

Consumer health in the United Arab Emirates was historically dominated by international manufacturers, due to a minimal presence of domestic manufacturing, and a heavy reliance on imported prescription and OTC medicines. However, the United Arab Emirates has been moving towards a more domestic focus on manufacturing in an effort to ease the high cost of imported medicines. Within this context, domestic major Julphar Gulf Pharmaceuticals holds the second largest retail value share in the consumer health market in the United Arab Emirates in 2010. The government heavily invested in the company to promote the development of its portfolio, which has become highly popular in certain categories, such as analgesics, cough, cold and allergy (hay fever) remedies and vitamins and dietary supplements.

Chemists/pharmacies maintains its leading position in distribution in 2010

Chemists/pharmacies remained the most important retail channel in consumer health in the United Arab Emirates in 2010, with many OTC products only available through this channel. Supermarkets/hypermarkets also rapidly gained importance, given its expansion and the growing range of products available. This channel supported the growth of certain consumer health categories, such as analgesics, wound care, medicated skin care and vitamins and dietary supplements. The role of supermarkets/hypermarkets in consumer health distribution further increased with the emergence of the pharmacy-in-hypermarket concept, which was first introduced by Carrefour and Bin Sina Pharmacy in 2009, and is expected to be rolled-out in most Carrefour outlets.

Healthy growth forecast for consumer health

In light of the economic downturn witnessed in 2009 and 2010, consumer health grew at slower rates compared with the review period, given lower consumer confidence and lower population growth. Although there were signs of recovery towards the end of 2010 in terms of improving consumer confidence, the economy in the United Arab Emirates is only expected to fully recover by 2012, and therefore another year of declining growth is expected in 2011, after which growth rates will gradually improve across consumer health. Key drivers of future growth are likely to remain high drug prices, the preference for branded products, and, more importantly, rising health-consciousness amongst consumers, which will support the growth of niche categories such as in vitamins and dietary supplements. However, growth rates will moderate compared with the pre-crisis boom years, firstly as the government moves to import cheaper generic OTC products and pushes local production in order to bring prices down, and secondly as the novelty of many categories fades.

Table of Contents

Table of Contents

Consumer Health in the United Arab Emirates - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to grow despite recessionary pressures

Self-medication rises to the mainstream

Julphar remains second despite the strength of international manufacturers

Chemists/pharmacies maintains its leading position in distribution in 2010

Healthy growth forecast for consumer health

KEY TRENDS AND DEVELOPMENTS

Consumer health continues to grow despite the economic downturn

Obesity and poor eating habits support demand for certain categories

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Counterfeiting

De-listing and de-reimbursement

Advertising

Packaging and labelling

Distribution

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in the United Arab Emirates - Company Profiles

Alphamed Group in Consumer Health (United Arab Emirates)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

Gulf Drug Establishment in Consumer Health (United Arab Emirates)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Julphar Gulf Pharmaceuticals in Consumer Health (United Arab Emirates)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 7 Julphar Gulf Pharmaceuticals: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 8 Julphar Gulf Pharmaceuticals: Competitive Position 2010

Adult Mouth Care in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care remained a niche category in 2010. It showed good growth over the review period, given its relatively emerging status; however, the tough economic conditions during 2009 and 2010 rendered adult mouth care products non-essential.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson (Middle East) led adult mouth care with a 21% retail value share in 2010, thanks to the popularity of its Daktarin and Oraldene brands, which are recommended/prescribed by most pharmacists and physicians. AstraZeneca Group was second with a 14% retail value share, owing to the strong presence of its Xylocaine brand.

PROSPECTS

  • Adult mouth care is expected to post a CAGR of 2% in constant value terms during the forecast period. Growth will be supported by rising awareness of mouth care, and an increasing tendency to self-medicate. The high cost of dentists in the United Arab Emirates, and more importantly its exclusion from medical insurance, will be a key driver of growth in adult mouth care over the forecast period. The latter will encourage consumers to take care of their oral health and self-medicate in order to save on expensive dentistry costs.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • The two key stories in 2010 were the increase in self-medication and the withdrawal of Johnson & Johnson’s Tylenol brand. Sales of analgesics were largely supported by the rising trend of self-medication, especially with the wide availability of OTC analgesics. Many consumers gained confidence in some of the best-selling analgesics, such as Panadol, Adol and Bayer Aspirin, to name a few, and they increasingly relied on such brands for various ailments. Longer working hours and stressful working conditions – both repercussions of the recent economic slowdown – led to higher consumption of analgesics.

SWITCHES

COMPETITIVE LANDSCAPE

  • Glaxo Wellcome led analgesics in 2010 with a retail value share of 19%, gaining two percentage points of share compared with 2009. This lead in analgesics was due to the established popularity of Panadol, the company’s flagship analgesic; its range of Panadol, Panadol Extra and Panadol Joint was complemented with Panadol Advance in 2010. The company’s lead in analgesics was also supported by Calpol, one of the leading brands in child-specific analgesics. In addition to Panadol’s positioning and the launch of Panadol Advance, the brand benefited from increasing marketing expenditure and a series of television advertisements which featured actual physicians recommending Panadol.

PROSPECTS

  • Self-medication is expected to become more popular over the forecast period. First, the Ministry of Health in the United Arab Emirates will further promote self-medication, which will result in consumers turning to analgesics to treat the symptoms of common ailments. Second, rising health-awareness amongst consumers will support the growth of analgesics, as consumers will opt to treat ailments with OTC analgesics rather than prescription drugs.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • In spite of the rising trend towards self-medication, consumers still held a negative sentiment towards self-medicating when it came to calming and sleeping products, which was partly formed based on media reports. Pharmacists and doctors also rarely recommend calming and sleeping products, except in certain cases where they are deemed necessary. Within this context, the growth potential for calming and sleeping products remained subdued in the United Arab Emirates. A few products are available OTC, such as Panadol Night, whilst others, such as Atarax, Xanax and Librax are available BTC.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pfizer held its lead in calming and sleeping in 2010 with a retail value share of 40%, given the popularity of its Xanax brand, followed by F Hoffmann La Roche (Dormicum) with a 20% share. Glaxo Wellcome was third; its Panadol Night brand held a share of 10%.

PROSPECTS

  • It is unlikely that calming and sleeping products will gain a significant presence during the forecast period. While the government is keen to encourage self-medication, it is more likely to focus on physical ailments. Meanwhile, consumers will continue to prefer to seek professional guidance from a doctor prior to taking calming and sleeping products, and will thus generally opt for prescription alternatives.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • The rise of health awareness and self-medication were the key stories of 2010. The Ministry of Health collaborated with major manufacturers to increase health awareness and self-medication in order to reduce the health bill, limiting the cost of cough, cold and allergy (hay fever) remedies and improving the wellbeing of the population. The government urged consumers to pay attention to potential side-effects, recommended doses, warning labels and enclosed leaflets, especially when it came to purchasing cough, cold and allergy (hay fever) remedies which promise quick relief.

SWITCHES

COMPETITIVE LANDSCAPE

  • SSP – the NBO for Boehringer Ingelheim –led in cough, cold and allergy (hay fever) remedies in 2010, with a retail value share of 17%. The company’s continued leadership relied on the established popularity of Atrovent and Mucosolvan.

PROSPECTS

  • Health awareness is expected to increase further over the forecast period, partly aided by the government’s promotional campaigns in association with leading domestic and international manufacturers. There is strong potential for self-medication, as consumers will be encouraged to visit chemists/pharmacies and parapharmacies/drugstores when suffering from coughs and colds, rather than seeking advice from a doctor. However, medical insurance will be the determinant here, as consumers will need to visit a doctor to purchase their medication via medical insurance.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • With obesity remaining a key feature of the population in the United Arab Emirates, the consumption of digestive remedies continued to grow in 2010. According to the Global School Health Survey, obesity in the United Arab Emirates is ranked 10th globally, with more than 30% of children aged 12-18 being overweight and at risk of becoming obese, and 12% of children aged 12-18 being obese. Obesity is not alarming only amongst children, but adults are also feeling the pinch. Consumers adopted unhealthier eating habits in the search for convenience, alongside changes in lifestyle. The large population of single persons in the country, coupled with long working hours, meant that people ate out more frequently, which led to an increase in conditions such as heartburn and indigestion. Having said that, the government has been actively involved in campaigns to crack down on obesity, raising consumer awareness and supporting the rise of self-medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson maintained its lead in digestive remedies with a retail value share of 20% in 2010. The company’s leading position was due to its wide and trusted brand portfolio, with flagship digestive remedies Motilium and Imodium. Motilium remained the best-selling brand in antiflatulents, and the second brand in digestive remedies, with a retail value share of 14%. Motilium benefits from pharmacists’ recommendations, and it is also prescribed by many paediatricians for infants and children.

PROSPECTS

  • Obesity is expected to remain a major problem over the forecast period due to certain demographics, such as longer working hours, more commuting time and less physical activity, which will in turn drive consumers to seek unhealthy eating options. Although rising health awareness might drive some consumers to eat healthier snacks, the majority of the population will be exposed to poor eating habits. Having said that, the forecast scenario provides a solid basis for the growth of digestive remedies.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • The lack of awareness of ear care continued to hold the category back from potential growth, and self-medication from making its way into ear care. Other than Western expatriates, most consumers in the country prefer to seek advice from ENT doctors rather than to self-medicate when it comes to ear care. Traditional methods for alleviating wax build-up, such as the use of olive oil and ear candling, continued to be popular ways of dealing with the problem. In general, for more serious ear-related conditions, even in the case of otitis, consumers are still inclined to seek professional advice, rather than to self-medicate.

SWITCHES

COMPETITIVE LANDSCAPE

  • Schering-Plough Corp maintained its lead in ear care with a 16% retail value share in 2010, thanks to its Garason brand, which continued to lead the category. Bristol-Myers Squibb Co trailed with a 14% value share, given the success of its Kenacomb brand, and Advent International Corp held a 12% share with Xerumenex.

PROSPECTS

  • Ear care is expected to remain a niche category, and self-medication is not expected to increase. This is partly due to the relatively lower frequency of ear care infections compared with other consumer health problems; however, the excessive use of mobile phones in this part of the world might favour sales of ear care products over the forecast period.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • The lower population size and growth – both repercussions of the economic downturn – took their toll on eye care. Due to the economic downturn manufacturers reduced their promotional activities, resulting in lower health awareness and self-medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • Allergan maintained its lead in eye care in 2010 with a retail value share of 38%. The company’s positioning relied on the popularity of brands such as Lacri, Celluvisc and Refresh Plus, which are usually recommended by pharmacists and ophthalmologists in the United Arab Emirates.

PROSPECTS

  • Self-medication is expected to strongly make its mark over the forecast period. Consumers – mostly those from the Middle East and the Indian subcontinent – will become more willing to self-medicate for eye infections. This trend is expected to be associated with minor illnesses, with consumers relying on repeat and referral methods to treat their eyes. They have gained confidence in certain products from companies such as Pfizer and Allergan, for example, and they also seek advice from pharmacists. However, in more severe cases, consumers prefer to consult an ophthalmologist.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2005-2010
  • Table 48 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 49 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 50 Eye Care Company Shares 2006-2010
  • Table 51 Eye Care Brand Shares 2007-2010
  • Table 52 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products continued to serve an important role in the consumer health market in the United Arab Emirates, and the category has become fairly mature. In addition to its focus on increasing the usage of herbal/traditional products, the Ministry of Health in the United Arab Emirates continued to encourage more consumers to trade up to packaged herbal/traditional products, rather than unpackaged products. However, consumers did not readily trade up to packaged products at a time of low consumer confidence, and many remained confident in unpackaged products. As for the government’s involvement in this area, it remained limited to institutions such as the Zayed Complex for Herbal Research and Traditional Medicine, focusing on Chinese medicine, which was created to encourage the usage of natural and herbal products.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products is an extremely fragmented category, entirely dependent on imports. Many brands lack a consistent distribution presence across the country. The leading two companies in 2010 were The Mentholatum Co Ltd with a 13% share and The Procter & Gamble Co with a 12% share.

PROSPECTS

  • The range of herbal/traditional products on offer in healthfood shops is expected to continue to widen during the forecast period, boosting consumer awareness. Chemists/pharmacies is also expected to see a good performance, with consumers viewing this channel as the most trustworthy. The increase in these channels is expected to be mainly at the expense of practitioners offering unpackaged herbal/traditional products, with the share of other non-grocery retailers thus declining. An area of potential growth over the longer term may be herbal/traditional calming and sleeping products, driven by increasingly stressful lifestyles and difficulty in sleeping amongst consumers. It is expected that there will be some migration from standard sleeping products towards their herbal counterparts, as consumers come to believe in the healthier nature of herbal and natural products.

CATEGORY DATA

  • Table 54 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 55 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 56 Herbal/Traditional Products Company Shares 2006-2010
  • Table 57 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 58 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 59 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • The fallout from the economic downturn took its toll on medicated skin care in 2010, as consumers cut their purchases in of products viewed as unnecessary, such as acne treatments, medicated shampoos and hair loss treatments. The impact was more pronounced amongst middle-income earners, as those on low incomes never purchase such products. Low consumer confidence during the year prompted many middle-income earners to either reduce or postpone their purchases of acne treatments, medicated shampoos and hair loss treatments, mainly driven by their exclusion from medical insurance.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline maintained its lead in medicated skin care in 2010 with a retail value share of 20%, which was a slight reduction from its 2009 share of 21%. The company continued to benefit from its portfolio being widely known amongst consumers, including landmark brands such as Betnovate in antipruritics, Alphosyl in medicated shampoos and Zentel in antiparasitics/lice treatments.

PROSPECTS

  • The economy in the United Arab Emirates is expected to recover by late 2011/early 2012, which will restore consumer confidence and result in restoring growth in impulse categories in medicated skin care. Consumers reduced their purchases of certain medicated skin care products towards the end of the review period, and the improving economic conditions are expected to support demand for niche categories such as medicated shampoos, acne treatments and hair loss treatments. In addition, the self-medication trend is expected to be common over the forecast period. As consumers increasingly gain confidence in certain medicated skin care products, these products are likely to encourage more consumers to seek help from widely available products, rather than visiting their doctor or ignoring the condition, driving growth of products such as acne treatments, antifungals, haemorrhoid treatments and hair loss treatments.

CATEGORY DATA

  • Table 60 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 61 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 62 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 63 Medicated Skin Care Brand Shares 2007-2010
  • Table 64 Hair Loss Treatments Brand Shares 2007-2010
  • Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • The government continued to press ahead with its clampdown on smoking, through widening tobacco bans and raising consumers’ awareness of the dangers of smoking. First, following the smoking ban which was introduced in various stages over the review period and culminated in the Federal Tobacco Law which was approved in 2009, the government has been considering extending the ban to other areas, such as parks, beaches, bars and nightclubs. Although this proposal remained under consideration at the time of writing, it might see the light over the forecast period. Second, the government continued to invest in public awareness campaigns against smoking. In 2010, the Health Authority of Abu Dhabi (HADD) started a programme to help its staff quit smoking, whereby it covered the entire cost of their treatment and follow-up consultations. Enrolment in the programme was available from mid-2010, and will remain in place for quite some time.

SWITCHES

COMPETITIVE LANDSCAPE

  • Johnson & Johnson (Middle East) held its lead in NRT smoking cessation aids with a 52% retail value share in 2010, given the popularity of its Nicorette brand, driven by a strong reputation amongst expatriates. Novartis Consumer Health remained in second position with a 36% value share, driven by its brand Nicotinell. In addition to its lead in NRT patches, Novartis benefited from its partnership with the Ministry of Health, whereby they jointly run a number of smoking cessation clinics. As is evident, the category is highly concentrated, with these two companies holding a combined value share of 88%.

PROSPECTS

  • The government is expected to press ahead with its clampdown on smoking over the forecast period. Smoking bans might be further implemented in other areas, such as bars/nightclubs and beaches/parks, along with associated fines. Higher taxation on tobacco products is also expected in 2011/2012, and more investment is also expected in public anti-tobacco campaigns. Accordingly, in this environment smokers will find it more difficult to maintain their habit, with a diminishing number of locations where they can smoke, rising costs and increasing social stigma related to smoking. The above measures are likely to become stricter over the forecast period in light of the rising deaths from conditions related to smoking. In addition, rising health awareness will benefit the category. As consumers become more conscious about health and wellness, they will increasingly appreciate the benefits of quitting smoking and hence NRT smoking cessation aids.

CATEGORY INDICATORS

  • Table 67 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 68 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 69 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 70 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 71 NRT Smoking Cessation Aids Company Shares 2006-2010
  • Table 72 NRT Smoking Cessation Aids Brand Shares 2007-2010
  • Table 73 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 74 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • With sports nutrition products considered luxuries and not necessities, the performance of the category was negatively affected by the fallout from the economic downturn. Many consumers cut their purchases of sports nutrition products during the last two years. The growth of the category was also constrained by the government’s control over advertising of these products, resulting in lower consumer awareness. It is also widely perceived that sports nutrition products are only for use by body builders, and they are all amino acids.

COMPETITIVE LANDSCAPE

  • General Nutrition Centers remained the leading player in sports nutrition in 2010, with a retail value share of 9%, thanks to a varied portfolio eliciting strong popularity amongst consumers of sports nutrition products. The company has a well-established and trusted reputation, and benefits from strong customer loyalty. The company initially sold its products solely through its own outlets in the United Arab Emirates, which was complemented in 2009 by adding some of its products in Carrefour hypermarkets. Universal Nutrition ranked second with a 4% value share, in light of limited distribution of its products compared with General Nutrition Centers.

PROSPECTS

  • New government initiatives to encourage healthier eating and more physical activity amongst young people are likely to encourage more people to visit gyms, which stands to potentially drive interest in sports nutrition products to build up muscle. However, growth will be hindered by the limited consumer group interested in these types of products, with these likely to remain younger adults, particularly men, who attend a gym as part of a more serious fitness regime.

CATEGORY DATA

  • Summary 9 Sports Nutrition: Brand Ranking by Format 2010
  • Table 75 Sales of Sports Nutrition: Value 2005-2010
  • Table 76 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 77 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 78 Sports Nutrition Company Shares 2006-2010
  • Table 79 Sports Nutrition Brand Shares 2007-2010
  • Table 80 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 81 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • Although low consumer confidence suppressed spending on non-essential items, rising health awareness gave vitamins and dietary supplements essential status amongst many consumers, namely upper-middle to high-income earners. As for other income groups, they cut back on trial purchases, as they increasingly felt the pinch from the economic crisis. As far as higher-income brackets were concerned, there was growing interest in preventative products such as vitamins and dietary supplements in an attempt to protect against ill-health, as well as for self-medication, as consumers became more knowledgeable about their vitamin needs depending on their respective health profiles. Vitamins and dietary supplements increased by 6% in current value terms in 2010, to reach sales of AED174 million.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Roche Holding maintained its lead in vitamins and dietary supplements with a 12% retail value share in 2010, thanks to a strong brand portfolio including household brands such as Redoxon and Arovit, to name a few. Redoxon in particular maintained its position as the best-selling brand of vitamin C in the United Arab Emirates, especially with the increasing usage of vitamin C for treating cold symptoms, as health-conscious consumers cut their purchases of cough, cold and allergy (hay fever) remedies. Nevertheless, the continuous new launches in the vibrant category of vitamins and dietary supplements led to a decline in the company’s share of half a percentage point in 2010. Brand-loyalty is minimal in vitamins and dietary supplements; accordingly, many consumers shifted to other brands, either because of their cheaper prices or additional functionalities.

PROSPECTS

  • Health and wellness will further strengthen its role in the lifestyles of consumers in the United Arab Emirates, helping to promote growth in vitamins and dietary supplements through increased penetration and higher frequency of use. The current economic slowdown, however, will continue to put pressure on disposable incomes, making consumers more mindful of their expenditure.

CATEGORY DATA

  • Summary 10 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 82 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 83 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 84 Dietary Supplements by Positioning 2006-2010
  • Table 85 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 86 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 87 Vitamins Brand Shares 2007-2010
  • Table 88 Dietary Supplements Brand Shares 2007-2010
  • Table 89 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 90 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • Obesity remained the key story in 2010, as the country had one of the highest obesity rates in the world due to unhealthy eating options and changing consumer lifestyles. Consumers in the United Arab Emirates have become used to fat- and carbohydrate-laden foods due to eating out more frequently. Changing consumer lifestyles have also taken their toll, as longer working hours led to adopting an unhealthy diet and sedentary lifestyle, leaving less time for physical exercise.

COMPETITIVE LANDSCAPE

  • General Nutrition Center led weight management with a 12% retail value share in 2010, as the company had a number of products gaining ground in the category in the United Arab Emirates, such as Slimquick Extreme. Vitabiotics followed with a retail value share of 7%, as the company aims to replicate its success in vitamins and dietary supplements in weight management with brands such as Dietrim in weight supplements. In meal replacement slimming products, both Unilever Group and Atkins Nutritionals dominate, as their respective brands Slim Fast and Atkins have a strong presence in the category.

PROSPECTS

  • Obesity is expected to remain the key story over the forecast period. As obesity rates remain high, the government will further step up its efforts to clamp down on the epidemic, which will raise the importance of weight management as a convenient solution to the obesity problem. Although the government’s efforts emphasise losing weight through conventional means, such as adjusting diet and exercise, rather than using weight management products, the convenience of weight management products will appeal to more and more consumers in light of busier lifestyles and longer working hours.

CATEGORY DATA

  • Table 91 Sales of Weight Management by Category: Value 2005-2010
  • Table 92 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 93 Weight Management Company Shares 2006-2010
  • Table 94 Weight Management Brand Shares 2007-2010
  • Table 95 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 96 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in the United Arab Emirates - Category Analysis

HEADLINES

TRENDS

  • The wound care category started showing more sophistication towards the end of the review period in terms of catering to consumers’ needs, either with value additions for older consumers or special characters for younger ones. First, manufacturers started launching products with value additions, such as those catering to burns, stopping blood flow and other kinds of minor injuries. Second, manufacturers focused on their young consumer base, such as with Hansaplast Disney plasters and 3M’s Nexcare Tattoo.

COMPETITIVE LANDSCAPE

  • Wound care was dominated by Johnson & Johnson in 2010, with a retail value share of 55%, thanks to the strong brand equity of its brand Band-Aid. Band-Aid has become synonymous with plasters, and most people ask for a “Band-Aid” and not a plaster when needing to cover a minor cut or burn. However, the rising competition in the category from other brands, such as Urgo, Nexcare and Hansaplast, led to a gradual decline in Johnson & Johnson’s share from 2008. The low consumer confidence in 2009 and 2010 led to trading down to cheaper brands such as Urgo, which remarkably boosted its share.

PROSPECTS

  • Manufacturers will increasingly focus on wound care products with additional functionality for older generations, and products with functionality and special characters for younger generations. This strategy proved successful towards the end of the review period; otherwise growth would have remained dented by low consumer confidence.

CATEGORY DATA

  • Table 97 Sales of Wound Care by Category: Value 2005-2010
  • Table 98 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 99 Wound Care Company Shares 2006-2010
  • Table 100 Wound Care Brand Shares 2007-2010
  • Table 101 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 102 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!